Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session

Live Q&A and discussion


02 Mar 2021


Mini Oral session


Fiona Thistlethwaite


F. Thistlethwaite1, D.S. Tan2, V. Moreno3, T. Sen4, M. Mates5, S.M. Galbraith6

Author affiliations

  • 1 The Christie NHS Foundation Trust, M20 4BX - Manchester/GB
  • 2 NUS-National University of Singapore-National University Health System (NUHS), Singapore/SG
  • 3 University Hospital "Fundacion Jimenez Diaz", Madrid/ES
  • 4 Medicine, Memorial Sloan Kettering Cancer Center, 10065 - New York/US
  • 5 Oncology Department, Cancer Centre of Southeastern Ontario, K7L 5P9 - Kingston/CA
  • 6 Oncology R&d Department, Research & Early Development Dpt., AstraZeneca - IMED Biotech, CB4 0WG - Cambridge/GB


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.